3-hydroxybutyric acid has been researched along with Weight Loss in 47 studies
3-Hydroxybutyric Acid: BUTYRIC ACID substituted in the beta or 3 position. It is one of the ketone bodies produced in the liver.
3-hydroxybutyric acid : A straight-chain 3-hydroxy monocarboxylic acid comprising a butyric acid core with a single hydroxy substituent in the 3- position; a ketone body whose levels are raised during ketosis, used as an energy source by the brain during fasting in humans. Also used to synthesise biodegradable plastics.
Weight Loss: Decrease in existing BODY WEIGHT.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Dapagliflozin is a potent and selective sodium glucose cotransporter-2 (SGLT2) inhibitor which promotes urinary glucose excretion and induces weight loss." | 7.78 | Weight loss induced by chronic dapagliflozin treatment is attenuated by compensatory hyperphagia in diet-induced obese (DIO) rats. ( Cullen, MJ; Devenny, JJ; Godonis, HE; Harvey, SJ; Pelleymounter, MA; Rooney, S, 2012) |
| "Three clinical studies were conducted: a bariatric surgery cohort study of participants with morbid obesity who underwent either Roux-en-Y gastric bypass (RYGB) or sleeve gastrectomy (SG) studied over four and twelve weeks, and two randomized placebo-controlled, crossover double blind studies of liraglutide vs." | 5.69 | Early metabolomic, lipid and lipoprotein changes in response to medical and surgical therapeutic approaches to obesity. ( Alexandrou, A; Angelidi, AM; Connelly, MA; Kokkinos, A; Mantzoros, CS; Mingrone, G; Sanoudou, D, 2023) |
| " Following weight loss, circulating concentrations of glucose, insulin, non-esterified fatty acids (NEFA), β-hydroxybutyrate (BHB), leptin, gastrointestinal hormones and subjective ratings of appetite were compared when subjects were ketotic, and after refeeding." | 3.79 | Ketosis and appetite-mediating nutrients and hormones after weight loss. ( Delbridge, E; Kriketos, A; Prendergast, LA; Proietto, J; Purcell, K; Shulkes, A; Sumithran, P, 2013) |
| "Dapagliflozin is a potent and selective sodium glucose cotransporter-2 (SGLT2) inhibitor which promotes urinary glucose excretion and induces weight loss." | 3.78 | Weight loss induced by chronic dapagliflozin treatment is attenuated by compensatory hyperphagia in diet-induced obese (DIO) rats. ( Cullen, MJ; Devenny, JJ; Godonis, HE; Harvey, SJ; Pelleymounter, MA; Rooney, S, 2012) |
| "Weight loss is effective in decreasing liver fat in subjects who are homozygous for the rs738409 PNPLA3 G or C allele." | 2.76 | Genetic variation in PNPLA3 (adiponutrin) confers sensitivity to weight loss-induced decrease in liver fat in humans. ( Ferrannini, E; Gastaldelli, A; Hakkarainen, A; Kotronen, A; Lundbom, J; Lundbom, N; Olkkonen, VM; Orho-Melander, M; Perttilä, J; Rissanen, A; Sevastianova, K; Suojanen, L; Yki-Järvinen, H, 2011) |
| "Unified Parkinson's Disease Rating Scale scores improved in all five during hyperketonemia, but a placebo effect was not ruled out." | 2.71 | Treatment of Parkinson disease with diet-induced hyperketonemia: a feasibility study. ( Boyar, K; Di Rocco, A; Heymsfield, SB; Hyams, K; Nonas, C; Vanitallie, TB, 2005) |
| "Progressive weight loss is a hallmark feature of Huntington's disease, yet we found that the ketogenic diet-which generally causes weight loss in normal animals-delayed the reduction in body weight of the transgenic mice." | 1.37 | A ketogenic diet delays weight loss and does not impair working memory or motor function in the R6/2 1J mouse model of Huntington's disease. ( Geiger, JD; Kawamura, M; Masino, SA; Ross, JL; Ruiz, TL; Ruskin, DN, 2011) |
| "Diabetic TPN rats without insulin treatment had weight loss and negative nitrogen balance during the experiment." | 1.30 | MCT/LCT emulsion ameliorate liver fat deposition in insulin-treated diabetic rats receiving total parenteral nutrition. ( Chen, WJ; Lin, MT; Yeh, SL, 1998) |
| " An apparent improvement in utilization of even-MCT was observed between 6 and 18 h, as evidenced by a twofold vs a sixfold increase in 3-OH-butyrate (BHBA) concentration 1 h after dosing and a twofold vs 12-fold increase in plasma fatty acid concentration." | 1.28 | Utilization of medium-chain triglycerides by neonatal piglets: II. Effects of even- and odd-chain triglyceride consumption over the first 2 days of life on blood metabolites and urinary nitrogen excretion. ( Benevenga, NJ; Crenshaw, TD; Odle, J, 1989) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (6.38) | 18.7374 |
| 1990's | 6 (12.77) | 18.2507 |
| 2000's | 14 (29.79) | 29.6817 |
| 2010's | 18 (38.30) | 24.3611 |
| 2020's | 6 (12.77) | 2.80 |
| Authors | Studies |
|---|---|
| Mank, MM | 1 |
| Reed, LF | 1 |
| Walton, CJ | 1 |
| Barup, MLT | 1 |
| Ather, JL | 1 |
| Poynter, ME | 1 |
| Nasser, S | 1 |
| Solé, T | 1 |
| Vega, N | 1 |
| Thomas, T | 1 |
| Balcerczyk, A | 1 |
| Strigini, M | 1 |
| Pirola, L | 1 |
| Spigoni, V | 1 |
| Cinquegrani, G | 1 |
| Iannozzi, NT | 1 |
| Frigeri, G | 1 |
| Maggiolo, G | 1 |
| Maggi, M | 1 |
| Parello, V | 1 |
| Dei Cas, A | 1 |
| Angelidi, AM | 1 |
| Kokkinos, A | 1 |
| Sanoudou, D | 1 |
| Connelly, MA | 1 |
| Alexandrou, A | 1 |
| Mingrone, G | 1 |
| Mantzoros, CS | 1 |
| Martins, C | 1 |
| Nymo, S | 1 |
| Coutinho, SR | 1 |
| Rehfeld, JF | 1 |
| Hunter, GR | 1 |
| Gower, BA | 1 |
| Katsuya, S | 1 |
| Kawata, Y | 1 |
| Goto, T | 1 |
| Tsubota, J | 1 |
| Sahagun, E | 1 |
| Ward, LM | 1 |
| Kinzig, KP | 1 |
| Stekovic, S | 1 |
| Hofer, SJ | 1 |
| Tripolt, N | 1 |
| Aon, MA | 1 |
| Royer, P | 1 |
| Pein, L | 1 |
| Stadler, JT | 1 |
| Pendl, T | 1 |
| Prietl, B | 1 |
| Url, J | 1 |
| Schroeder, S | 1 |
| Tadic, J | 1 |
| Eisenberg, T | 1 |
| Magnes, C | 1 |
| Stumpe, M | 1 |
| Zuegner, E | 1 |
| Bordag, N | 1 |
| Riedl, R | 1 |
| Schmidt, A | 1 |
| Kolesnik, E | 1 |
| Verheyen, N | 1 |
| Springer, A | 1 |
| Madl, T | 1 |
| Sinner, F | 1 |
| de Cabo, R | 1 |
| Kroemer, G | 1 |
| Obermayer-Pietsch, B | 1 |
| Dengjel, J | 1 |
| Sourij, H | 1 |
| Pieber, TR | 1 |
| Madeo, F | 1 |
| Futatani, T | 1 |
| Shimao, A | 1 |
| Ina, S | 1 |
| Higashiyama, H | 1 |
| Fujita, S | 1 |
| Ueno, K | 1 |
| Igarashi, N | 1 |
| Hatasaki, K | 1 |
| Iovane, B | 1 |
| Cangelosi, AM | 1 |
| Bonaccini, I | 1 |
| Di Mauro, D | 1 |
| Scarabello, C | 1 |
| Panigari, A | 1 |
| Tiri, A | 1 |
| Mastrorilli, C | 1 |
| Fainardi, V | 1 |
| Dodi, I | 1 |
| Vanelli, M | 1 |
| Newman, AW | 1 |
| Miller, A | 1 |
| Leal Yepes, FA | 1 |
| Bitsko, E | 1 |
| Nydam, D | 1 |
| Mann, S | 1 |
| LaFountain, RA | 1 |
| Miller, VJ | 1 |
| Barnhart, EC | 1 |
| Hyde, PN | 1 |
| Crabtree, CD | 1 |
| McSwiney, FT | 1 |
| Beeler, MK | 1 |
| Buga, A | 1 |
| Sapper, TN | 1 |
| Short, JA | 1 |
| Bowling, ML | 1 |
| Kraemer, WJ | 1 |
| Simonetti, OP | 1 |
| Maresh, CM | 1 |
| Volek, JS | 1 |
| Hughes, TE | 1 |
| Kim, DD | 1 |
| Marjason, J | 1 |
| Proietto, J | 2 |
| Whitehead, JP | 1 |
| Vath, JE | 1 |
| Haviland, JA | 1 |
| Reiland, H | 1 |
| Butz, DE | 1 |
| Tonelli, M | 1 |
| Porter, WP | 1 |
| Zucchi, R | 1 |
| Scanlan, TS | 1 |
| Chiellini, G | 1 |
| Assadi-Porter, FM | 1 |
| Sumithran, P | 1 |
| Prendergast, LA | 1 |
| Delbridge, E | 1 |
| Purcell, K | 1 |
| Shulkes, A | 1 |
| Kriketos, A | 1 |
| Poff, AM | 1 |
| Ari, C | 1 |
| Seyfried, TN | 1 |
| D'Agostino, DP | 1 |
| Matoulek, M | 2 |
| Svobodova, S | 1 |
| Vetrovska, R | 1 |
| Stranska, Z | 1 |
| Svacina, S | 2 |
| Chen, JY | 1 |
| Tran, C | 1 |
| Hwang, L | 1 |
| Deng, G | 1 |
| Jung, ME | 1 |
| Faull, KF | 1 |
| Levine, MS | 1 |
| Cepeda, C | 1 |
| Franco, M | 1 |
| Contreras, C | 1 |
| Place, NJ | 1 |
| Bozinovic, F | 1 |
| Nespolo, RF | 1 |
| Tulipani, S | 1 |
| Griffin, J | 1 |
| Palau-Rodriguez, M | 1 |
| Mora-Cubillos, X | 1 |
| Bernal-Lopez, RM | 1 |
| Tinahones, FJ | 1 |
| Corkey, BE | 1 |
| Andres-Lacueva, C | 1 |
| Mitsuhashi, Y | 1 |
| Nagaoka, D | 1 |
| Ishioka, K | 1 |
| Bigley, KE | 1 |
| Okawa, M | 1 |
| Otsuji, K | 1 |
| Bauer, JE | 1 |
| Ruskin, DN | 1 |
| Ross, JL | 1 |
| Kawamura, M | 1 |
| Ruiz, TL | 1 |
| Geiger, JD | 1 |
| Masino, SA | 1 |
| Sevastianova, K | 1 |
| Kotronen, A | 1 |
| Gastaldelli, A | 1 |
| Perttilä, J | 1 |
| Hakkarainen, A | 1 |
| Lundbom, J | 1 |
| Suojanen, L | 1 |
| Orho-Melander, M | 1 |
| Lundbom, N | 1 |
| Ferrannini, E | 1 |
| Rissanen, A | 1 |
| Olkkonen, VM | 1 |
| Yki-Järvinen, H | 1 |
| Devenny, JJ | 1 |
| Godonis, HE | 1 |
| Harvey, SJ | 1 |
| Rooney, S | 1 |
| Cullen, MJ | 1 |
| Pelleymounter, MA | 1 |
| Swithers, SE | 1 |
| McCurley, M | 1 |
| Wright, GL | 1 |
| Morrison, R | 1 |
| Fultz, ME | 1 |
| Wright, G | 1 |
| Mccumbee, W | 1 |
| Wehner, P | 1 |
| Studeny, M | 1 |
| Meckling, KA | 1 |
| O'Sullivan, C | 1 |
| Saari, D | 1 |
| Vanitallie, TB | 1 |
| Nonas, C | 1 |
| Di Rocco, A | 1 |
| Boyar, K | 1 |
| Hyams, K | 1 |
| Heymsfield, SB | 1 |
| Coleman, MD | 1 |
| Nickols-Richardson, SM | 1 |
| Kunesová, M | 1 |
| Braunerová, R | 1 |
| Hlavatý, P | 1 |
| Tvrzická, E | 1 |
| Stanková, B | 1 |
| Skrha, J | 1 |
| Hilgertová, J | 1 |
| Hill, M | 1 |
| Kopecký, J | 1 |
| Wagenknecht, M | 1 |
| Hainer, V | 1 |
| Parízková, J | 1 |
| Zák, A | 1 |
| Slater, GJ | 1 |
| Rice, AJ | 1 |
| Sharpe, K | 1 |
| Mujika, I | 1 |
| Jenkins, D | 1 |
| Hahn, AG | 1 |
| Salas, A | 1 |
| Esteve, M | 1 |
| Mar Grasa, M | 1 |
| Remesar, X | 1 |
| Johnston, CS | 1 |
| Tjonn, SL | 1 |
| Swan, PD | 1 |
| White, A | 1 |
| Hutchins, H | 1 |
| Sears, B | 1 |
| Oikawa, S | 1 |
| Oetzel, GR | 1 |
| Vazquez, JA | 1 |
| Kazi, U | 1 |
| Madani, N | 1 |
| Keim, NL | 1 |
| Anderson, BL | 1 |
| Barbieri, TF | 1 |
| Wu, MM | 1 |
| Teraki, Y | 1 |
| Teraki, E | 1 |
| Kawashima, M | 1 |
| Nagashima, M | 1 |
| Shiohara, T | 1 |
| Santos, GA | 1 |
| Silversides, FG | 1 |
| Jonsson, NN | 1 |
| McGowan, MR | 1 |
| McGuigan, K | 1 |
| Davison, TM | 1 |
| Hussain, AM | 1 |
| Kafi, M | 1 |
| Matschoss, A | 1 |
| Yeh, SL | 1 |
| Lin, MT | 1 |
| Chen, WJ | 1 |
| Dardzinski, BJ | 1 |
| Smith, SL | 1 |
| Towfighi, J | 1 |
| Williams, GD | 1 |
| Vannucci, RC | 1 |
| Smith, MB | 1 |
| Rae, A | 1 |
| Bond, D | 1 |
| Evans, S | 1 |
| North, F | 1 |
| Roberman, B | 1 |
| Walters, B | 1 |
| Ivany, JM | 1 |
| Anderson, DE | 1 |
| Tornquist, SJ | 1 |
| Cebra, CK | 1 |
| Van Saun, RJ | 1 |
| Smith, BB | 1 |
| Mattoon, JS | 1 |
| Odle, J | 1 |
| Benevenga, NJ | 1 |
| Crenshaw, TD | 1 |
| Whitaker, DA | 1 |
| Smith, EJ | 1 |
| Kelly, JM | 1 |
| Tisdale, MJ | 1 |
| Brennan, RA | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Comparative Study of the Effects of Roux en Y Gastric Bypass and Sleeve Gastrectomy on Postprandial Gut Hormone Responses, Glycemia and Lipid Profile, Weight Loss, and Indices of Cardiovascular Risk[NCT03851874] | 28 participants (Actual) | Interventional | 2011-10-31 | Completed | |||
| Liraglutide in Obesity and Diabetes: Identification of CNS Targets Using fMRI[NCT01562678] | Phase 4 | 28 participants (Actual) | Interventional | 2012-03-31 | Completed | ||
| Saxenda: Underlying Mechanisms and Clinical Outcomes[NCT02944500] | Phase 4 | 28 participants (Actual) | Interventional | 2016-11-30 | Active, not recruiting | ||
| The Impact of Intermittent Fasting on Human Metabolism and Cell Autophagy[NCT02673515] | 60 participants (Actual) | Interventional | 2015-04-30 | Completed | |||
| Use of Oral 40% Destrogel to Prevent Hypoglycaemia in Late-term Births and SGA or LGA Term Newborns[NCT04185766] | 172 participants (Actual) | Interventional | 2018-11-23 | Completed | |||
| Impact of Pre-Military Life Experiences/Exposures on Active-Duty Service Members' Psychological Health and Adjustment Over a Marine Battalion Deployment Cycle[NCT06070025] | 300 participants (Anticipated) | Observational | 2023-01-22 | Enrolling by invitation | |||
| Keto-diet for Intubated Critical Care COVID-19 (KICC-COVID19)[NCT04358835] | 0 participants (Actual) | Interventional | 2020-09-01 | Withdrawn (stopped due to Study did not begin enrollment, multiple competing studies at same institution) | |||
| Effectiveness of the Treatment With Dapagliflozin and Metformin Compared to Metformin Monotherapy for Weight Loss on Diabetic and Prediabetic Patients With Obesity Class III[NCT03968224] | Phase 2/Phase 3 | 90 participants (Anticipated) | Interventional | 2018-07-07 | Recruiting | ||
| Combined Effects of SGLT2 Inhibition and GLP-1 Receptor Agonism on Food Intake, Body Weight and Central Satiety and Reward Circuits in Obese T2DM Patients[NCT03361098] | Phase 4 | 65 participants (Actual) | Interventional | 2017-09-18 | Completed | ||
| Ketogenic Diet Interventions in Parkinson's Disease: Safeguarding the Gut Microbiome[NCT05469997] | 50 participants (Anticipated) | Interventional | 2023-01-31 | Not yet recruiting | |||
| Effect of a Lipidic and Proteic Controlled Diet on Resting Energy Expenditure, Body Composition and Symptoms in Patients With Parkinson's Disease[NCT02687698] | 36 participants (Anticipated) | Interventional | 2016-02-29 | Enrolling by invitation | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Effect size (region of interest z-scores, derived from z-maps of the brain) shown below is the difference in parietal cortex activation to highly desirable (high fat or high calorie, e.g. cakes, pies, fries) versus less desirable (low fat or low calorie, e.g. vegetables, fruits) food cues for each treatment condition (liraglutide or placebo) at the end of the treatment period. (NCT01562678)
Timeframe: 18 days of Liraglutide or placebo treatment
| Intervention | z-scores of activation in cortex (Mean) |
|---|---|
| Liraglutide | -0.42 |
| Placebo | 0.53 |
"HOMA-Index was calculated by using the following formula:~HOMA-IR= FPG(mmol/l)*FSI (U/l)/22.5 FSI=fasting serum insulin FPG=fasting plasma glucose" (NCT02673515)
Timeframe: 4 weeks (from Baseline to 4 weeks)
| Intervention | no unit (Mean) |
|---|---|
| Alternate Day Fasting | 0.05 |
| Control Group | 0.06 |
ISI was calculated by using the following formula: ISI=0,222-0,00333 x BMI-0,0000779 x Ins120-0,000422 x age FSI=fasting serum insulin FPG=fasting plasma glucose (NCT02673515)
Timeframe: 4 weeks (from Baseline to 4 weeks)
| Intervention | no unit (Median) |
|---|---|
| Alternate Day Fasting | 0 |
| Control Group | 0 |
"Matsuda index was calculated by using the following formula:~Matsuda-Index = 10000√(FPG∗FSI)∗(mean glucose*mean insulin) FSI=fasting serum insulin FPG=fasting plasma glucose" (NCT02673515)
Timeframe: 4 weeks (from Baseline to 4 weeks)
| Intervention | no unit (Median) |
|---|---|
| Alternate Day Fasting | -0.4 |
| Control Group | -0.7 |
QUICKI was calculated by using the following formula: QUICKI= log(FSI)+log (FPG) FSI=fasting serum insulin FPG=fasting plasma glucose (NCT02673515)
Timeframe: 4 weeks (from Baseline to 4 weeks)
| Intervention | no unit (Median) |
|---|---|
| Alternate Day Fasting | 0 |
| Control Group | 0 |
Change of blood pressure from Baseline to 4 weeks (NCT02673515)
Timeframe: 4 weeks
| Intervention | mmHg (Median) | |
|---|---|---|
| Systolic blood pressure | Diastolic blood pressure | |
| Alternate Day Fasting | -4.5 | -2.5 |
| Control Group | -1 | 0 |
2 reviews available for 3-hydroxybutyric acid and Weight Loss
| Article | Year |
|---|---|
Activation of G protein-coupled receptors by ketone bodies: Clinical implication of the ketogenic diet in metabolic disorders.
Topics: 3-Hydroxybutyric Acid; Acetoacetates; Carbohydrates; Diet, Ketogenic; Humans; Ketone Bodies; Ketones | 2022 |
Metabolomics-guided insights on bariatric surgery versus behavioral interventions for weight loss.
Topics: 3-Hydroxybutyric Acid; Adipose Tissue; Amino Acids, Branched-Chain; Bariatric Surgery; Behavior Ther | 2016 |
12 trials available for 3-hydroxybutyric acid and Weight Loss
| Article | Year |
|---|---|
Early metabolomic, lipid and lipoprotein changes in response to medical and surgical therapeutic approaches to obesity.
Topics: 3-Hydroxybutyric Acid; Acetoacetates; Citrates; Cohort Studies; Diabetes Mellitus, Type 2; Gastrecto | 2023 |
Early metabolomic, lipid and lipoprotein changes in response to medical and surgical therapeutic approaches to obesity.
Topics: 3-Hydroxybutyric Acid; Acetoacetates; Citrates; Cohort Studies; Diabetes Mellitus, Type 2; Gastrecto | 2023 |
Early metabolomic, lipid and lipoprotein changes in response to medical and surgical therapeutic approaches to obesity.
Topics: 3-Hydroxybutyric Acid; Acetoacetates; Citrates; Cohort Studies; Diabetes Mellitus, Type 2; Gastrecto | 2023 |
Early metabolomic, lipid and lipoprotein changes in response to medical and surgical therapeutic approaches to obesity.
Topics: 3-Hydroxybutyric Acid; Acetoacetates; Citrates; Cohort Studies; Diabetes Mellitus, Type 2; Gastrecto | 2023 |
Early metabolomic, lipid and lipoprotein changes in response to medical and surgical therapeutic approaches to obesity.
Topics: 3-Hydroxybutyric Acid; Acetoacetates; Citrates; Cohort Studies; Diabetes Mellitus, Type 2; Gastrecto | 2023 |
Early metabolomic, lipid and lipoprotein changes in response to medical and surgical therapeutic approaches to obesity.
Topics: 3-Hydroxybutyric Acid; Acetoacetates; Citrates; Cohort Studies; Diabetes Mellitus, Type 2; Gastrecto | 2023 |
Early metabolomic, lipid and lipoprotein changes in response to medical and surgical therapeutic approaches to obesity.
Topics: 3-Hydroxybutyric Acid; Acetoacetates; Citrates; Cohort Studies; Diabetes Mellitus, Type 2; Gastrecto | 2023 |
Early metabolomic, lipid and lipoprotein changes in response to medical and surgical therapeutic approaches to obesity.
Topics: 3-Hydroxybutyric Acid; Acetoacetates; Citrates; Cohort Studies; Diabetes Mellitus, Type 2; Gastrecto | 2023 |
Early metabolomic, lipid and lipoprotein changes in response to medical and surgical therapeutic approaches to obesity.
Topics: 3-Hydroxybutyric Acid; Acetoacetates; Citrates; Cohort Studies; Diabetes Mellitus, Type 2; Gastrecto | 2023 |
Daily Intake of D-β-Hydroxybutyric Acid (D-BHB) Reduces Body Fat in Japanese Adult Participants: A Randomized, Double-Blind, Placebo-Controlled Study.
Topics: 3-Hydroxybutyric Acid; Adipose Tissue; Adult; Body Composition; Double-Blind Method; East Asian Peop | 2023 |
Alternate Day Fasting Improves Physiological and Molecular Markers of Aging in Healthy, Non-obese Humans.
Topics: 3-Hydroxybutyric Acid; Adult; Aging; Biomarkers; Body Mass Index; Caloric Restriction; Energy Intake | 2019 |
Capillary Blood Ketone Levels as an Indicator of Inadequate Breast Milk Intake in the Early Neonatal Period.
Topics: 3-Hydroxybutyric Acid; Acid-Base Imbalance; Biomarkers; Breast Feeding; Capillaries; Dehydration; Fe | 2017 |
Ascending dose-controlled trial of beloranib, a novel obesity treatment for safety, tolerability, and weight loss in obese women.
Topics: 3-Hydroxybutyric Acid; Adiponectin; Aminopeptidases; Anti-Obesity Agents; Aspergillus; Biological Pr | 2013 |
Genetic variation in PNPLA3 (adiponutrin) confers sensitivity to weight loss-induced decrease in liver fat in humans.
Topics: 3-Hydroxybutyric Acid; Adipose Tissue; Adult; Caloric Restriction; Dietary Carbohydrates; Energy Met | 2011 |
Comparison of a low-fat diet to a low-carbohydrate diet on weight loss, body composition, and risk factors for diabetes and cardiovascular disease in free-living, overweight men and women.
Topics: 3-Hydroxybutyric Acid; Adult; Blood Pressure; Body Composition; Cardiovascular Diseases; Diabetes Me | 2004 |
Treatment of Parkinson disease with diet-induced hyperketonemia: a feasibility study.
Topics: 3-Hydroxybutyric Acid; Acetoacetates; Aged; Antiparkinson Agents; Cholesterol; Combined Modality The | 2005 |
Treatment of Parkinson disease with diet-induced hyperketonemia: a feasibility study.
Topics: 3-Hydroxybutyric Acid; Acetoacetates; Aged; Antiparkinson Agents; Cholesterol; Combined Modality The | 2005 |
Treatment of Parkinson disease with diet-induced hyperketonemia: a feasibility study.
Topics: 3-Hydroxybutyric Acid; Acetoacetates; Aged; Antiparkinson Agents; Cholesterol; Combined Modality The | 2005 |
Treatment of Parkinson disease with diet-induced hyperketonemia: a feasibility study.
Topics: 3-Hydroxybutyric Acid; Acetoacetates; Aged; Antiparkinson Agents; Cholesterol; Combined Modality The | 2005 |
The influence of n-3 polyunsaturated fatty acids and very low calorie diet during a short-term weight reducing regimen on weight loss and serum fatty acid composition in severely obese women.
Topics: 3-Hydroxybutyric Acid; Caloric Restriction; Diet, Reducing; Dietary Supplements; Docosahexaenoic Aci | 2006 |
Ketogenic low-carbohydrate diets have no metabolic advantage over nonketogenic low-carbohydrate diets.
Topics: 3-Hydroxybutyric Acid; Adult; Arachidonic Acid; Body Composition; Body Mass Index; Cholesterol, LDL; | 2006 |
Protein metabolism during weight reduction with very-low-energy diets: evaluation of the independent effects of protein and carbohydrate on protein sparing.
Topics: 3-Hydroxybutyric Acid; Adult; Amino Acids; Ammonia; Analysis of Variance; Blood Glucose; Body Compos | 1995 |
A randomised controlled trial of dietary energy restriction in the management of obese women with gestational diabetes.
Topics: 3-Hydroxybutyric Acid; Adult; Birth Weight; Blood Glucose; Diabetes, Gestational; Diet, Reducing; En | 2000 |
33 other studies available for 3-hydroxybutyric acid and Weight Loss
| Article | Year |
|---|---|
Therapeutic ketosis decreases methacholine hyperresponsiveness in mouse models of inherent obese asthma.
Topics: 3-Hydroxybutyric Acid; Animals; Asthma; Bronchial Hyperreactivity; Diet, High-Fat; Diet, Ketogenic; | 2022 |
Ketogenic diet administration to mice after a high-fat-diet regimen promotes weight loss, glycemic normalization and induces adaptations of ketogenic pathways in liver and kidney.
Topics: 3-Hydroxybutyric Acid; Animals; Blood Glucose; Diet, High-Fat; Diet, Ketogenic; Dietary Carbohydrate | 2022 |
Association between Fat-Free Mass Loss, Changes in Appetite, and Weight Regain in Individuals with Obesity.
Topics: 3-Hydroxybutyric Acid; Adult; Appetite; Ghrelin; Humans; Male; Middle Aged; Obesity; Peptide YY; Wei | 2023 |
Attenuation of stress-induced weight loss with a ketogenic diet.
Topics: 3-Hydroxybutyric Acid; Animals; Behavior, Animal; Body Weight; Corticosterone; Corticotropin-Releasi | 2019 |
Diabetic ketoacidosis at the onset of Type 1 diabetes in young children Is it time to launch a tailored campaign for DKA prevention in children <5 years?
Topics: 3-Hydroxybutyric Acid; Adolescent; Child; Child, Preschool; Diabetes Mellitus, Type 1; Diabetic Keto | 2018 |
The effect of the transition period and postpartum body weight loss on macrophage infiltrates in bovine subcutaneous adipose tissue.
Topics: 3-Hydroxybutyric Acid; Animals; Cattle; Diet; Energy Metabolism; Female; Lactation; Lipolysis; Macro | 2019 |
Extended Ketogenic Diet and Physical Training Intervention in Military Personnel.
Topics: 3-Hydroxybutyric Acid; Adipose Tissue; Adult; Body Composition; Diet, Ketogenic; Female; Humans; Mal | 2019 |
NMR-based metabolomics and breath studies show lipid and protein catabolism during low dose chronic T(1)AM treatment.
Topics: 3-Hydroxybutyric Acid; Animals; Body Weight; Breath Tests; Dietary Proteins; Dose-Response Relations | 2013 |
Ketosis and appetite-mediating nutrients and hormones after weight loss.
Topics: 3-Hydroxybutyric Acid; Adult; Aged; Appetite Regulation; Body Mass Index; Caloric Restriction; Diet, | 2013 |
The ketogenic diet and hyperbaric oxygen therapy prolong survival in mice with systemic metastatic cancer.
Topics: 3-Hydroxybutyric Acid; Animals; Blood Glucose; Cell Line, Tumor; Combined Modality Therapy; Diet, Ke | 2013 |
Post-exercise changes of beta hydroxybutyrate as a predictor of weight changes.
Topics: 3-Hydroxybutyric Acid; Adult; Biomarkers; Exercise Therapy; Female; Humans; Middle Aged; Obesity; Ti | 2014 |
Partial Amelioration of Peripheral and Central Symptoms of Huntington's Disease via Modulation of Lipid Metabolism.
Topics: 3-Hydroxybutyric Acid; Animals; Cholesterol; Diet, Ketogenic; Female; Huntington Disease; Inhibitory | 2016 |
Leptin levels, seasonality and thermal acclimation in the Microbiotherid marsupial Dromiciops gliroides: Does photoperiod play a role?
Topics: 3-Hydroxybutyric Acid; Acclimatization; Adiposity; Animals; Chile; Cholesterol; Hibernation; Leptin; | 2017 |
Postprandial lipid-related metabolites are altered in dogs fed dietary diacylglycerol and low glycemic index starch during weight loss.
Topics: 3-Hydroxybutyric Acid; Animals; Cholesterol; Dietary Carbohydrates; Dietary Fats; Diglycerides; Dog | 2010 |
A ketogenic diet delays weight loss and does not impair working memory or motor function in the R6/2 1J mouse model of Huntington's disease.
Topics: 3-Hydroxybutyric Acid; Age Factors; Animals; Diet, Ketogenic; Disease Models, Animal; Female; Humans | 2011 |
Weight loss induced by chronic dapagliflozin treatment is attenuated by compensatory hyperphagia in diet-induced obese (DIO) rats.
Topics: 3-Hydroxybutyric Acid; Animals; Anti-Obesity Agents; Benzhydryl Compounds; Blood Glucose; Caloric Re | 2012 |
Weight loss induced by chronic dapagliflozin treatment is attenuated by compensatory hyperphagia in diet-induced obese (DIO) rats.
Topics: 3-Hydroxybutyric Acid; Animals; Anti-Obesity Agents; Benzhydryl Compounds; Blood Glucose; Caloric Re | 2012 |
Weight loss induced by chronic dapagliflozin treatment is attenuated by compensatory hyperphagia in diet-induced obese (DIO) rats.
Topics: 3-Hydroxybutyric Acid; Animals; Anti-Obesity Agents; Benzhydryl Compounds; Blood Glucose; Caloric Re | 2012 |
Weight loss induced by chronic dapagliflozin treatment is attenuated by compensatory hyperphagia in diet-induced obese (DIO) rats.
Topics: 3-Hydroxybutyric Acid; Animals; Anti-Obesity Agents; Benzhydryl Compounds; Blood Glucose; Caloric Re | 2012 |
Effects of 2-mercaptoacetate on ingestive behavior in 18- and 21-day-old rats.
Topics: 3-Hydroxybutyric Acid; Aging; Animals; Animals, Suckling; Blood Glucose; Body Weight; Diet; Dose-Res | 2002 |
Effect of fasting on vascular contractility in lean and obese Zucker rats.
Topics: 3-Hydroxybutyric Acid; Animals; Aorta, Thoracic; Blood Pressure; Disease Models, Animal; Epinephrine | 2003 |
Urinary ketones reflect serum ketone concentration but do not relate to weight loss in overweight premenopausal women following a low-carbohydrate/high-protein diet.
Topics: 3-Hydroxybutyric Acid; Adult; Biomarkers; Diet, Reducing; Dietary Carbohydrates; Dietary Proteins; F | 2005 |
Body-mass management of Australian lightweight rowers prior to and during competition.
Topics: 3-Hydroxybutyric Acid; Adult; Age Factors; Australia; Body Water; Body Weight; CD3 Complex; Dehydrat | 2005 |
Rats treated with oleoyl-oestrone maintain glucidic homeostasis: comparisons with a pair-fed model.
Topics: 3-Hydroxybutyric Acid; Adiponectin; Administration, Oral; Animals; Anti-Obesity Agents; Blood Glucos | 2005 |
Decreased insulin response in dairy cows following a four-day fast to induce hepatic lipidosis.
Topics: 3-Hydroxybutyric Acid; Animals; Blood Glucose; Body Composition; Cattle; Fasting; Fatty Acids, Nones | 2006 |
Moderate diet restriction alters the substrate and hormone response to exercise.
Topics: 3-Hydroxybutyric Acid; Adult; Blood Glucose; Body Composition; Carbohydrate Metabolism; Carbohydrate | 1994 |
Ketosis is involved in the origin of prurigo pigmentosa.
Topics: 3-Hydroxybutyric Acid; Adolescent; Adult; Diabetes Mellitus, Type 1; Feeding and Eating Disorders; F | 1996 |
Utilization of the sex-linked gene for imperfect albinism (S*ALS). 1. Effect of early weight loss on chick metabolism.
Topics: 3-Hydroxybutyric Acid; Albinism; Animals; Body Temperature; Body Weight; Chickens; Docosahexaenoic A | 1996 |
Relationships among calving season, heat load, energy balance and postpartum ovulation of dairy cows in a subtropical environment.
Topics: 3-Hydroxybutyric Acid; Animals; Blood Glucose; Cattle; Cohort Studies; Energy Metabolism; Female; Ho | 1997 |
MCT/LCT emulsion ameliorate liver fat deposition in insulin-treated diabetic rats receiving total parenteral nutrition.
Topics: 3-Hydroxybutyric Acid; Animals; Blood Glucose; Cholesterol; Diabetes Mellitus, Experimental; Diabete | 1998 |
Increased plasma beta-hydroxybutyrate, preserved cerebral energy metabolism, and amelioration of brain damage during neonatal hypoxia ischemia with dexamethasone pretreatment.
Topics: 3-Hydroxybutyric Acid; Animals; Animals, Newborn; Brain; Dexamethasone; Energy Metabolism; Hypoxia-I | 2000 |
Propylene glycol toxicosis in a llama.
Topics: 3-Hydroxybutyric Acid; Abdomen; Animals; Anti-Ulcer Agents; Aspartate Aminotransferases; Camelids, N | 2001 |
Metabolic changes and induction of hepatic lipidosis during feed restriction in llamas.
Topics: 3-Hydroxybutyric Acid; Animals; Aspartate Aminotransferases; Bile Acids and Salts; Biopsy, Needle; C | 2001 |
Utilization of medium-chain triglycerides by neonatal piglets: II. Effects of even- and odd-chain triglyceride consumption over the first 2 days of life on blood metabolites and urinary nitrogen excretion.
Topics: 3-Hydroxybutyric Acid; Animals; Animals, Newborn; Blood Glucose; Hematocrit; Hydroxybutyrates; Nitro | 1989 |
Milk production, weight changes and blood biochemical measurements in dairy cattle receiving recombinant bovine somatotropin.
Topics: 3-Hydroxybutyric Acid; Animals; Cattle; Eating; Female; Growth Hormone; Hydroxybutyrates; Lactation; | 1989 |
A comparison of long-chain triglycerides and medium-chain triglycerides on weight loss and tumour size in a cachexia model.
Topics: 3-Hydroxybutyric Acid; Adenocarcinoma; Animals; Cachexia; Colonic Neoplasms; Dietary Fats; Disease M | 1988 |